FIELD: medicine. SUBSTANCE: present invention describes immunostimulating agents for treating acute and chronic infections caused by bacteria and viruses. Product: methyl ether of N-[2-cyano- 3(1,4-dihydro-1-phenylindeno [1,2-c] pyrazol-3-yl)- oxopropanoyl] glycine, m.p. 253-255 C. Product: N-[2- cyano-3-(1,4-dihydro-1-phenylindeno [1,2-c]pyrazol-3-yl)- 3-oxopropanoyl] glycine, m.p. 247-249 C (decom). EFFECT: improved properties of the pharmaceutical composition.
Authors
Dates
1998-04-27—Published
1990-12-19—Filed